354
Participants
Start Date
May 29, 2019
Primary Completion Date
January 10, 2022
Study Completion Date
January 10, 2022
LY900014
Administered SC
Insulin Lispro
Administered SC
Insulin Glargine
Administered SC
Insulin Degludec
Administered SC
Unidad de Investigaci�n Cl�nica Cardiometabolica de Occidente, Guadalajara
Unidad de patologia Clinica, Guadalajara
"Hospital Universitario Dr. Jose Eleuterio Gonzalez", Monterrey
Beijing Peking Union Medical College Hospital, Beijing
Shengjing Hospital of China Medical University, Shenyang
The First Hospital of Jilin University, Changchun
No.2 Hospital Affiliated to Jilin University, Changchun
The Fourth Affiliated Hospital of Harbin Medical University, Harbin
Shanghai Putuo District Center Hospital, Shanghai
Shanghai Tenth People's Hospital, Shanghai
Xinhua Hospital Affiliated to Shanghai Jiaotong University School of Medicine, Shanghai
Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School, Nanjing
The First Hospital of Nanjing, Nanjing
Jiangsu Province Hospital, Nanjing
Sir Run Run Hospital of Nanjing Medical University, Nanjing
Affiliated Hospital of Jiangsu University, Zhenjiang
Changzhou No.2 People's Hospital, Changzhou
The Second Affiliated Hospital of Soochow University, Suzhou
The Second People's Hospital of Hefei, Hefei
The Second Xiangya Hospital of Central South University, Changsha
The First People's Hospital of Changde City, Changde
The First Affiliated Hospital of Henan University of Science &Technology, Luoyang
Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou
Shantou University Medical College No.2 Affiliated Hospital, Shantou
Shenzhen Second People's Hospital, Shenzhen
Dongguan people's hospital, Dongguan
West China Hospital Sichuan University, Chengdu
Centro de Investigaciones Metabólicas (CINME), CABA
Centro Médico Viamonte, CABA
Cent Priva Especiali Médicas Ambulatorias Inve Clin CEMAIC, Córdoba
Eli Lilly and Company
INDUSTRY